ABSTRACT
Introduction
Ghrelin is a peptide hormone that was purified from the stomach that can cause the release of growth hormone from the anterior pituitary gland (1) . It has subsequently been found that ghrelin is predominantly released from the stomach prior to feeding (2) , although other tissues have been shown to express the gene as well (3) . Peripheral injections of ghrelin have been shown to increase feeding in both rats (4) and humans (5) , and a course of injections leads to increased obesity in rats (4) . Therefore, ghrelin can be seen as an important link between the stomach, appetite and metabolism; as well as playing a role in growth hormone release.
The aim of this study was to establish whether ghrelin interacts with any other component of plasma. It was hypothesized that any interaction might be an important factor in determining the activity or longevity of ghrelin in plasma. Furthermore, an interaction in the plasma might be involved in the creation of the two distinct forms of ghrelin (6) : the acylated form, in which octanoic acid is covalently bound to the peptide, and the more prevalent desacyl form in which the peptide is unmodified. The acylated form of ghrelin stimulates the release of growth hormone from the pituitary gland, therefore any mechanism that might convert one form of ghrelin into the other could be an important factor in controlling the activity of ghrelin.
Methods
A peptide corresponding to mature human ghrelin, with a cysteine residue substituted for the serine residue at the third position (S3C ghrelin), was synthesised by Fmoc chemistry using a Rainin PS3 automatic peptide synthesizer (Protein Technologies, USA). The peptide was purified to over 90% homogeneity by reverse-phase chromatography using a Varian 500LC HPLC. The molecular weight of the purified peptide was verified by SELDI-mass spectrometry. The purified peptide (10 mg) was covalently bound to 2 ml of Sulpholink matrix (Pierce, UK), via the sulphydryl group of the introduced cysteine. Briefly, the peptide was dissolved in 1 ml of PBS and then gently agitated with the resin for one hour at room temperature. The slurry was then centrifuged for one minute at 1,000g and the supernatant removed. Any remaining iodoacetyl binding sites on the matrix were then blocked by incubation with 15 mM free cysteine for 20 minutes. A negative control matrix, with no peptide attached, was only blocked with free cysteine. The two matrices were washed in 100 mM glycine, pH 2.5 and then neutralized in PBS.
Blood was taken into EDTA from an individual who had not eaten for over 12 hours.
The plasma was purified from the blood cells by centrifugation at 1,500g for 10 minutes, and the two column matrices were each incubated with 10 ml of plasma for one hour. Each column was then sequentially washed with 5 ml of PBS; 5 ml of PBS + 1M sodium chloride; 5 ml of PBS + 2M sodium chloride and then the proteins that had remained bound were eluted with 5 ml of 100 mM glycine (pH 2.5). All samples were concentrated into 100 µl of PBS using Amicon Centricon preparators (cut-off 10 kDa). Samples were made up in Laemmli buffer and 10 µl was used for SDS-PAGE, prior to staining with Coomassie blue, whilst 20 µl samples were used for protein sequencing. Gels were blotted onto PVDF membrane (Amersham, UK), at 1 mA/cmwith 0.1 ml of ghrelin-Sulpholink matrix, and 100 µl of PBS or an equivalent volume containing either free ghrelin or paraoxon. The matrices were then sequentially washed with; 1 ml of PBS; 1 ml of PBS + 1M sodium chloride; 1 ml of PBS + 2M sodium chloride and then the remaining bound proteins were eluted with 1 ml of 100 mM glycine (pH 2.5). The glycine-eluted samples were then washed extensively and concentrated into 100 µl of PBS using Amicon Centricon preparators. Samples of 10 µl were made up in Laemmli buffer and run on SDS-PAGE for staining with Coomassie blue.
Human low-(LDL) and high-(HDL) density lipoproteins were isolated from fresh blood, donated by healthy fasted volunteers, by a modification of the method of Chung & coworkers (1980). Whole plasma was loaded into a discontinuous gradient (1.3 g/ml and 1.006 g/ml), which formed into a linear gradient between upper and lower density limits during centrifugation for 150 minutes in a Beckman 70Ti rotor at 160,000g. The density ranges of the low-and high-density lipoprotein classes are 1.019 -1.063 g/ml and 1.063 -1.21 g/ml respectively. Serum albumin was removed from HDL using Blue Sepharose chromatography (Pharmacia). The lipoproteins were de-salted on a G25 column, fractions were monitored for absorbance at 280 nm and samples were analyzed for immunoreactivity by RIA (Phoenix Pharmaceuticals, USA).
Lipoprotein fractions, along with a positive control of acylated ghrelin (Phoenix Pharmaceuticals, USA), were spotted onto methanol-whetted PVDF membrane in triplicate.
The membrane was blocked in 5% milk powder in PBS containing 0.1% Tween 20 for one hour, and then probed for 16 hours with 1% milk powder in PBS-T containing 1/1,000 antiserum that had been raised against S3C ghrelin coupled to keyhole limpet hemocyanin (KLH). The membrane was then probed with 1/5,000 goat anti-rabbit IgG conjugated to horseradish peroxidase (Sigma, UK) in 1% milk powder in PBS-T for one hour and then extensively washed in PBS-T and visualized by enhanced chemiluminescence (Amersham, UK).
Results
Affinity chromatography, using an engineered form of ghrelin, was used to identify the moieties in plasma that could bind to ghrelin. The samples that were eluted by the acid glycine were separated by SDS-PAGE and then electro-blotted onto PVDF membrane and stained for protein. All the stained bands in the sample on the PVDF membrane were subjected to Nterminal sequencing, and proteins were identified by at least eight cycles of Edman degradation.
The most abundant protein that was purified by the ghrelin-affinity chromatography To establish whether any endogenous ghrelin is bound to HDL or LDL in human plasma, the lipoproteins were purified by density-gradient ultracentrifugation. When the sodium bromide was removed from the HDL fraction by gel filtration, the ghrelin immunoreactive species co-migrated with the lipoprotein ( Figure 3A ). This shows that ghrelin migrated as a high molecular weight species during density-gradient ultracentrifugation and gel filtration and co-migrated with HDL under both of these purification processes.
In figure 3B , the fractions of lipoprotein were spotted in triplicate onto PVDF membrane and probed by an antibody raised against ghrelin. The antibody recognised ghrelin in human plasma, but not in low-density lipoprotein. The antibody bound ghrelin in the HDL fraction, and this was not reduced by the removal of serum albumin from this fraction.
Ghrelin-affinity chromatography was also performed on serum from a rabbit that had been fed ad libidum. Only PON I and Apo A-I were identified after acid-glycine elution from the column (data not shown). It could be that the difference in these results is due to different properties of the proteins from different species, or that the calcium in the serum, or the 
Discussion
PON I has been shown to possess esterase activity and there is an ester bond in ghrelin that links the octanoic acid to the third residue, a serine (1). However, the present affinity chromatography data were obtained using a matrix that has the peptide bound via a thioether bond at the point at which the octanoic acid would be attached to the peptide via an ester bond. The purified peptide was immobilized via the sulphydryl group to Sulpholink matrix, which has a spacer group containing a 12-carbon chain between the sulphydryl-specific iodoacetyl group and the cross-linked agarose matrix. Therefore, this engineered form of ghrelin has an aliphatic chain attached to the peptide at the correct position, but via a thioether linkage, rather than the ester linkage in natural ghrelin.
Engineered forms of ghrelin, in which the vulnerable ester linkage is exchanged for a more robust bond, may alter the bio-stability and activity of ghrelin. If PON I breaks ghrelin down to the des-acyl form, then PON I may be a suitable target for developing drugs to control the bio-stability, and therefore activity, of endogenous ghrelin. This interaction may offer opportunities for therapeutic intervention in the control of either appetite or lipoprotein metabolism.
No previous data has suggested a link between ghrelin and a sub-type of HDL.
However, both ghrelin and this species of HDL are present in plasma during fasting, although they are released from different tissues, therefore it should be possible for these two serum components to interact.
The relationship between growth hormone (GH), ghrelin and HDL is not fully understood. Both GH deficiency and excess are associated with an increased risk of atherosclerosis. Acromegaly is associated with both low HDL levels (11) and low ghrelin levels (12) . GH deficiency is associated with low ghrelin levels (13), but it is unclear whether there are changes in HDL levels in these patients (14, 15) . The present data suggest a significant link between HDL and ghrelin, but it is unclear whether the changes in ghrelin and HDL levels in these pathophysiological states are causally linked, and whether low ghrelin levels might influence the course of atherosclerosis in these patients, or any other groups.
This study raises some questions about the physiology of ghrelin and HDL. Further investigations will be required to distinguish which form of ghrelin can interact with the species of HDL, and to measure the proportions of bound and free ghrelin in plasma. The interaction may affect the biological activities of these molecules, so this ratio could be an important factor in health and disease. This ratio may vary between individuals, or fluctuate with ghrelin levels, or in specific disease states. It is also possible that ghrelin interacts with other moieties in the plasma under different conditions, and further work will be required to fully characterize the interactions and physiology of ghrelin in the blood.
In conclusion, the interaction between ghrelin and this species of HDL is a link between hunger, growth hormone release and lipid transport, as part of the response to fasting.
Further research may establish the importance of this interaction for health and disease. A) Endogenous ghrelin and HDL migrate together during gel-filtration chromatography. HDL isolated from fasted human plasma by density-gradient ultracentrifugation, was de-salted by by guest on 
